Using lipidomics and proteomics to find biomarkers that predict progression of multiple sclerosis
-
Professor George Jelinek
Project Details
This study, in collaboration with the Baker Institute and Walter and Eliza Hall Institute, will examine in a longitudinal study blood samples from people with MS and matched controls, looking for novel lipid and protein biomarkers that can predict the progression of MS.
Identifying such biomarkers is critical to enable appropriate targeting of expensive and potentially toxic pharmaceuticals and invasive medical procedures such as autologous haematopoietic stem cell transplantation to those people with MS whose disease is likely to progress rapidly.
Researchers
Collaborators
Dr Peter Meikle, Baker Institute
Dr Andrew Webb, Walter and Eliza Hall Institute